MedTrace Logo

Prediction of Cardiovascular Events in Vulnerable Patients Following Acute Coronary Syndrome

NCT01500902 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2015-09-23

No results posted yet for this study

Summary

The purpose of this study is to determine if testing patients for endothelial dysfunction will help identify which patients are more likely at risk to have another heart attack in the future. Study participants will undergo mental stress testing while at the same time being connected to a device that measures endothelial function via the Endopat device. These same participants will also undergo a sleep study via the Watchpat device.

Conditions

  • Acute Coronary Syndrome

Interventions

OTHER

EndoPAT testing (non invasive device)

Using the EndoPAT device, we will assess endothelial function.

OTHER

WatchPAT testing (non-invasive device)

Using the WATCHPAT device we will assess sleep apnea.

Sponsors & Collaborators

  • Qatar National Research Fund

    collaborator OTHER

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Amir Lerman, M.D. · Mayo Clinic

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-03-31
Completion
2015-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01500902 on ClinicalTrials.gov